Nuclear Medicine and Biology
Volume 33, Issue 6 , Pages 715-722 , August 2006

A 99mTc-labeled gemcitabine bisphosphonate drug conjugate as a probe to assess the potential for targeted chemotherapy of metastatic bone cancer

  • Amal A. El-Mabhouh

      Affiliations

    • Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta T6G 2N8, Canada
    • ,
  • Christo A. Angelov

      Affiliations

    • Department of Chemistry, University of Alberta, Edmonton, Alberta T6G 2G2, Canada
    • ,
  • Ron Cavell

      Affiliations

    • Department of Chemistry, University of Alberta, Edmonton, Alberta T6G 2G2, Canada
    • ,
  • John R. Mercer

      Affiliations

    • Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta T6G 2N8, Canada
    • Faculty of Medicine, Oncologic Imaging, Cross Cancer Institute, Edmonton, Alberta T6G 1Z2, Canada
    • Corresponding Author InformationCorresponding author. Faculty of Medicine, Oncologic Imaging, Cross Cancer Institute, Edmonton, Alberta, Canada T6G 1Z2. Tel.: +1 780 989 4312; fax: +1 780 432 8483.

Received 12 January 2006 ,Revised 14 June 2006 ,Accepted 15 June 2006.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0969-8051(06)00105-3

doi: 10.1016/j.nucmedbio.2006.06.004

Nuclear Medicine and Biology
Volume 33, Issue 6 , Pages 715-722 , August 2006

Article Tools

* Image Usage & Resolution